Young-In Chi1,2,3, Timothy J Stodola1,2, Thiago M De Assuncao1,3, Elise N Leverence1, Swarnendu Tripathi1,2, Nikita R Dsouza1,2, Angela J Mathison1,2,3, Donald G Basel1,4, Brian F Volkman5, Brian C Smith5, Gwen Lomberk1,3,6, Michael T Zimmermann1,2,7, Raul Urrutia8,9,10,11. 1. Genomic Sciences and Precision Medicine Center (GSPMC), Medical College of Wisconsin, Milwaukee, WI, USA. 2. Bioinformatics Research and Development Laboratory, and Precision Medicine Simulation Unit, GSPMC, Medical College of Wisconsin, Milwaukee, WI, USA. 3. Division of Research, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USA. 4. Division of Pediatric Genetics, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA. 5. Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI, USA. 6. Department of Pharmacology and Toxicology, Medical College of Wisconsin, Milwaukee, WI, USA. 7. Clinical and Translational Sciences Institute, Medical College of Wisconsin, Milwaukee, WI, USA. 8. Genomic Sciences and Precision Medicine Center (GSPMC), Medical College of Wisconsin, Milwaukee, WI, USA. rurrutia@mcw.com. 9. Bioinformatics Research and Development Laboratory, and Precision Medicine Simulation Unit, GSPMC, Medical College of Wisconsin, Milwaukee, WI, USA. rurrutia@mcw.com. 10. Division of Research, Department of Surgery, Medical College of Wisconsin, Milwaukee, WI, USA. rurrutia@mcw.com. 11. Division of Pediatric Genetics, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA. rurrutia@mcw.com.
Abstract
BACKGROUND: Kabuki syndrome is a genetic disorder that affects several body systems and presents with variations in symptoms and severity. The syndrome is named for a common phenotype of faces resembling stage makeup used in a Japanese traditional theatrical art named kabuki. The most frequent cause of this syndrome is mutations in the H3K4 family of histone methyltransferases while a smaller percentage results from genetic alterations affecting the histone demethylase, KDM6A. Because of the rare presentation of the latter form of the disease, little is known about how missense changes in the KDM6A protein sequence impact protein function. RESULTS: In this study, we use molecular mechanic and molecular dynamic simulations to enhance the annotation and mechanistic interpretation of the potential impact of eleven KDM6A missense variants found in Kabuki syndrome patients. These variants (N910S, D980V, S1025G, C1153R, C1153Y, P1195L, L1200F, Q1212R, Q1248R, R1255W, and R1351Q) are predicted to be pathogenic, likely pathogenic or of uncertain significance by sequence-based analysis. Here, we demonstrate, for the first time, that although Kabuki syndrome missense variants are found outside the functionally critical regions, they could affect overall function by significantly disrupting global and local conformation (C1153R, C1153Y, P1195L, L1200F, Q1212R, Q1248R, R1255W and R1351Q), chemical environment (C1153R, C1153Y, P1195L, L1200F, Q1212R, Q1248R, R1255W and R1351Q), and/or molecular dynamics of the catalytic domain (all variants). In addition, our approaches predict that many mutations, in particular C1153R, could allosterically disrupt the key enzymatic interactions of KDM6A. CONCLUSIONS: Our study demonstrates that the KDM6A Kabuki syndrome variants may impair histone demethylase function through various mechanisms that include altered protein integrity, local environment, molecular interactions and protein dynamics. Molecular dynamics simulations of the wild type and the variants are critical to gain a better understanding of molecular dysfunction. This type of comprehensive structure- and MD-based analyses should help develop improved impact scoring systems to interpret the damaging effects of variants in this protein and other related proteins as well as provide detailed mechanistic insight that is not currently predictable from sequence alone.
BACKGROUND: Kabuki syndrome is a genetic disorder that affects several body systems and presents with variations in symptoms and severity. The syndrome is named for a common phenotype of faces resembling stage makeup used in a Japanese traditional theatrical art named kabuki. The most frequent cause of this syndrome is mutations in the H3K4 family of histone methyltransferases while a smaller percentage results from genetic alterations affecting the histone demethylase, KDM6A. Because of the rare presentation of the latter form of the disease, little is known about how missense changes in the KDM6A protein sequence impact protein function. RESULTS: In this study, we use molecular mechanic and molecular dynamic simulations to enhance the annotation and mechanistic interpretation of the potential impact of eleven KDM6A missense variants found in Kabuki syndrome patients. These variants (N910S, D980V, S1025G, C1153R, C1153Y, P1195L, L1200F, Q1212R, Q1248R, R1255W, and R1351Q) are predicted to be pathogenic, likely pathogenic or of uncertain significance by sequence-based analysis. Here, we demonstrate, for the first time, that although Kabuki syndrome missense variants are found outside the functionally critical regions, they could affect overall function by significantly disrupting global and local conformation (C1153R, C1153Y, P1195L, L1200F, Q1212R, Q1248R, R1255W and R1351Q), chemical environment (C1153R, C1153Y, P1195L, L1200F, Q1212R, Q1248R, R1255W and R1351Q), and/or molecular dynamics of the catalytic domain (all variants). In addition, our approaches predict that many mutations, in particular C1153R, could allosterically disrupt the key enzymatic interactions of KDM6A. CONCLUSIONS: Our study demonstrates that the KDM6A Kabuki syndrome variants may impair histone demethylase function through various mechanisms that include altered protein integrity, local environment, molecular interactions and protein dynamics. Molecular dynamics simulations of the wild type and the variants are critical to gain a better understanding of molecular dysfunction. This type of comprehensive structure- and MD-based analyses should help develop improved impact scoring systems to interpret the damaging effects of variants in this protein and other related proteins as well as provide detailed mechanistic insight that is not currently predictable from sequence alone.
Authors: Aditi Gupta; Nikita R Dsouza; Yuri A Zarate; Rachel Lombardo; Robert Hopkin; Allison R Linehan; Jamela Simpson; Julie McCarrier; Katherine E Agre; Ralitza H Gavrilova; Michael C Stephens; Rayna M Grothe; Kristin G Monaghan; Yili Xie; Donald Basel; Raul A Urrutia; Conrad R Cole; Eric W Klee; Michael T Zimmermann Journal: Eur J Med Genet Date: 2019-11-25 Impact factor: 2.708
Authors: G Grant Welstead; Menno P Creyghton; Steve Bilodeau; Albert W Cheng; Styliani Markoulaki; Richard A Young; Rudolf Jaenisch Journal: Proc Natl Acad Sci U S A Date: 2012-07-23 Impact factor: 11.205
Authors: Md Saiful Islam; Thomas M Leissing; Rasheduzzaman Chowdhury; Richard J Hopkinson; Christopher J Schofield Journal: Annu Rev Biochem Date: 2018-03-01 Impact factor: 23.643
Authors: Charu Kaiwar; Michael T Zimmermann; Matthew J Ferber; Zhiyv Niu; Raul A Urrutia; Eric W Klee; Dusica Babovic-Vuksanovic Journal: Cold Spring Harb Mol Case Stud Date: 2017-11-21
Authors: Margot A Cousin; Michael T Zimmermann; Angela J Mathison; Patrick R Blackburn; Nicole J Boczek; Gavin R Oliver; Gwen A Lomberk; Raul A Urrutia; David R Deyle; Eric W Klee Journal: Cold Spring Harb Mol Case Stud Date: 2017-07-05
Authors: Young-In Chi; Timothy J Stodola; Thiago M De Assuncao; Elise N Leverence; Brian C Smith; Brian F Volkman; Angela J Mathison; Gwen Lomberk; Michael T Zimmermann; Raul Urrutia Journal: Comput Struct Biotechnol J Date: 2022-04-28 Impact factor: 6.155
Authors: Young-In Chi; Timothy J Stodola; Thiago M De Assuncao; Elise N Leverence; Swarnendu Tripathi; Nikita R Dsouza; Angela J Mathison; Donald G Basel; Brian F Volkman; Brian C Smith; Gwen Lomberk; Michael T Zimmermann; Raul Urrutia Journal: Orphanet J Rare Dis Date: 2021-06-01 Impact factor: 4.303